Investors in Credit Suisse Group AG (Symbol: CS) saw new options begin trading this week, for the November 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...
The high-performance 2025 M4 coupe gets even sharper, faster, and lighter with its new CS trim for those wanting track-day attitude and street civility. In the world of BMW, a Competition Sport—or “CS ...
The world premiere of the BMW M3 CS Touring also marked another first - the inaugural BMW global debut in Australia - at the Mount Panorama Motor Racing Circuit, which is set to host the Bathurst ...
The front end remains a “love it or hate it” feature with the extended kidney grilles, but the rest of the M3 CS Touring is sharp looking. Far from looking like a mundane station wagon, the M3 CS ...
The new CS has big shoes to fill, and it'll attempt that with more power for more money. We're big fans of the BMW 2 Series here at MotorTrend. Not only did Scott Evans call the 2020 BMW M2 CS "the ...
BMW has released the first official images of the upcoming M2 CS, offering a clean look at the coupe’s design ahead of its full reveal later this week. BMW has released official images of the upcoming ...
The BMW M2 is already an impressive sports car, but rumors of a more powerful and track-focused variant have been generating buzz for some time. Dubbed the M2 CS, this highly anticipated performance ...
CS:GO Source 2 has been rumoured for a while now, with fans of the biggest game on Steam expecting the online shooter to get upgraded imminently to the same engine powering Half-Life: Alyx. Well, ...
Credit Suisse Group has successfully acquired M. Klein & Company’s (MK&C’s) investment banking business The Klein Group, making further progress with the carveout of Credit Suisse First Boston (CS ...
As part of its massive restructuring plan, Credit Suisse (NYSE:CS) mapped out actions to carve out its investment banking business and revive the CS First Boston name by acquiring the boutique ...
CAMBRIDGE, Mass., Sept. 30, 2025 /PRNewswire/ -- Clear Scientific Inc., a clinical stage biopharmaceutical company focused on the development of first-in-class small molecules to reverse acute ...